Albumin Human

CHEMBL1201451 Phase 4 Aprobado Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

The most abundant protein normally found in human blood plasma, used medically as an intravenous infusion to restore blood volume in patients who have lost large amounts of protein through burns, surgery, trauma, or liver disease. It helps maintain fluid balance between blood vessels and body tissues and serves as a carrier for various substances throughout the bloodstream.

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The most abundant protein normally found in human blood plasma, used medically as an intravenous infusion to restore blood volume in patients who have lost large amounts of protein through burns, surgery, trauma, or liver disease. It helps maintain fluid balance between blood vessels and body tissues and serves as a carrier for various substances throughout the bloodstream.

Yes, Albumin Human is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201451. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.